Rui-Ming Yan

974 total citations
8 papers, 474 citations indexed

About

Rui-Ming Yan is a scholar working on Molecular Biology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Rui-Ming Yan has authored 8 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Immunology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Rui-Ming Yan's work include Extracellular vesicles in disease (3 papers), Immune cells in cancer (3 papers) and Reproductive System and Pregnancy (2 papers). Rui-Ming Yan is often cited by papers focused on Extracellular vesicles in disease (3 papers), Immune cells in cancer (3 papers) and Reproductive System and Pregnancy (2 papers). Rui-Ming Yan collaborates with scholars based in China and United Kingdom. Rui-Ming Yan's co-authors include Chenfei Zhou, Sha Wu, Xiang‐Guang Wu, Wei Wang, Wen-Fei Wei, Mei Zhong, Lei Huang, Xiaojing Chen, Yanhong Yu and Hongyan Yi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Cell Death and Differentiation.

In The Last Decade

Rui-Ming Yan

8 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rui-Ming Yan China 6 303 232 191 143 41 8 474
Hsin‐Yi Lan Taiwan 5 236 0.8× 167 0.7× 90 0.5× 219 1.5× 10 0.2× 6 463
Karen Slattery Ireland 8 226 0.7× 130 0.6× 242 1.3× 109 0.8× 12 0.3× 10 423
Baihua Luo China 14 218 0.7× 164 0.7× 69 0.4× 112 0.8× 15 0.4× 17 377
Manlong Qi China 9 379 1.3× 321 1.4× 69 0.4× 69 0.5× 76 1.9× 15 514
Lang Fang China 9 440 1.5× 350 1.5× 81 0.4× 52 0.4× 36 0.9× 16 544
Roman A. Zingarelli United States 4 304 1.0× 227 1.0× 54 0.3× 47 0.3× 17 0.4× 8 374
C. Liu China 8 162 0.5× 130 0.6× 85 0.4× 143 1.0× 24 0.6× 11 336
Meina Yan China 12 256 0.8× 154 0.7× 55 0.3× 49 0.3× 29 0.7× 18 365
Stacy Hultine United States 5 308 1.0× 278 1.2× 47 0.2× 74 0.5× 26 0.6× 6 414
Yolanda Sanchez-Ripoll United Kingdom 7 340 1.1× 159 0.7× 53 0.3× 228 1.6× 20 0.5× 7 479

Countries citing papers authored by Rui-Ming Yan

Since Specialization
Citations

This map shows the geographic impact of Rui-Ming Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui-Ming Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui-Ming Yan more than expected).

Fields of papers citing papers by Rui-Ming Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui-Ming Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui-Ming Yan. The network helps show where Rui-Ming Yan may publish in the future.

Co-authorship network of co-authors of Rui-Ming Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Rui-Ming Yan. A scholar is included among the top collaborators of Rui-Ming Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui-Ming Yan. Rui-Ming Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Liang, Luo-Jiao, Yang Yang, Wen-Fei Wei, et al.. (2021). Tumor-secreted exosomal Wnt2B activates fibroblasts to promote cervical cancer progression. Oncogenesis. 10(3). 42 indexed citations
2.
Zhou, Chenfei, Yanmei Zhang, Rui-Ming Yan, et al.. (2020). Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironment. Cell Death and Differentiation. 28(2). 715–729. 77 indexed citations
3.
Zhang, Yanmei, Yang Yang, Zhimin Wang, et al.. (2020). CD40 Accelerates the Antigen-Specific Stem-Like Memory CD8+ T Cells Formation and Human Papilloma Virus (HPV)-Positive Tumor Eradication. Frontiers in Immunology. 11. 1012–1012. 15 indexed citations
4.
Chen, Xiaojing, Rui-Ming Yan, Yanmei Zhang, et al.. (2019). Tumor-associated Macrophages Promote Invasion and Metastasis of Cervical Cancer. SHILAP Revista de lepidopterología. 46(3). 212–217. 1 indexed citations
5.
Chen, Xiaojing, Zi‐Ci Wang, Wen-Fei Wei, et al.. (2019). Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment. Cell Death and Disease. 10(7). 508–508. 99 indexed citations
6.
Wang, Zhi, Yali Liu, & Rui-Ming Yan. (2019). The ambient wind impact on eddy current distribution in air cooling island. AIP Advances. 9(12). 2 indexed citations
7.
Zhou, Chenfei, Jing Ma, Lei Huang, et al.. (2018). Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1. Oncogene. 38(8). 1256–1268. 160 indexed citations
8.
Chen, Xiaojing, Lingfei Han, Xiang‐Guang Wu, et al.. (2017). Clinical Significance of CD163+ and CD68+ Tumor-associated Macrophages in High-risk HPV-related Cervical Cancer. Journal of Cancer. 8(18). 3868–3875. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026